“…For example; CGRP has been shown to be upregulated in the dorsal root ganglion in models of neuropathic and inflammatory pain (Chao et al, 2008;Iwakura et al, 2010), and has been shown to have a significant role in neurogenic (Lin et al, 2007), dermal, intradermal and subcutaneous inflammation Seybold et al, 1995;Malcangio and Bowery, 1996;Lofgren et al, 1997). A recent study has also demonstrated a role for CGRP in central sensitisation (Marquez de Prado et al, 2009). In addition, there is evidence that the CGRP antagonist CGRP 8-37 has antinociceptive effects in models of central neuropathic pain (Bennett et al, 2000), and spinal nerve-mediated inflammatory (Yu et al, 1996a(Yu et al, , 1998 and neuropathic pain (Yu et al, 1996b).…”